Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Flatt

Showing results (81-90 of 325) with videos related to

Pageof 33
Sort By:
Bone|June 18, 2016
High fat-fed diabetic mice present with profound alterations of the osteocyte networkGuillaume Mabilleau, Rodolphe Perrot, Peter R Flatt, et al.
Biochemical Pharmacology|December 6, 2020
The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xeninSarah L Craig, Victor A Gault, Peter R Flatt, et al.
Plos One|August 30, 2018
Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed miceFinbarr P M O'Harte, Vadivel Parthsarathy, Christopher Hogg, et al.
Clinical Science (London, England : 1979)|July 28, 2005
L-Alanine induces changes in metabolic and signal transduction gene expression in a clonal rat pancreatic beta-cell line and protects from pro-inflammatory cytokine-induced apoptosisGrainne A Cunningham, Neville H McClenaghan, Peter R Flatt, et al.
Biological Chemistry|March 16, 2013
Effects of lipotoxicity on a novel insulin-secreting human pancreatic β-cell line, 1.1B4Srividya Vasu, Neville H McClenaghan, Jane T McCluskey, et al.
Experimental Cell Research|June 2, 2015
Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicitySrividya Vasu, R Charlotte Moffett, Neville H McClenaghan, et al.
Chemmedchem|November 10, 2012
(Val(8))GLP-1-Glu-PAL: a GLP-1 agonist that improves hippocampal neurogenesis, glucose homeostasis, and β-cell function in high-fat-fed miceRachael Lennox, David W Porter, Peter R Flatt, et al.
The Journal of Endocrinology|June 11, 2024
Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?Ryan A Lafferty, Peter R Flatt, Victor A Gault, et al.
Clinical Science (London, England : 1979)|February 22, 2011
Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesityVictor A Gault, Barry D Kerr, Patrick Harriott, et al.
World Journal of Diabetes|November 30, 2016
Implanting 1.1B4 human β-cell pseudoislets improves glycaemic control in diabetic severe combined immune deficient miceAlastair D Green, Srividya Vasu, Neville H McClenaghan, et al.
Pageof 33

Showing results (81-90 of 325) with videos related to

Sort By:
Pageof 33
Bone|June 18, 2016
High fat-fed diabetic mice present with profound alterations of the osteocyte networkGuillaume Mabilleau, Rodolphe Perrot, Peter R Flatt, et al.
Biochemical Pharmacology|December 6, 2020
The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xeninSarah L Craig, Victor A Gault, Peter R Flatt, et al.
Plos One|August 30, 2018
Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed miceFinbarr P M O'Harte, Vadivel Parthsarathy, Christopher Hogg, et al.
Clinical Science (London, England : 1979)|July 28, 2005
L-Alanine induces changes in metabolic and signal transduction gene expression in a clonal rat pancreatic beta-cell line and protects from pro-inflammatory cytokine-induced apoptosisGrainne A Cunningham, Neville H McClenaghan, Peter R Flatt, et al.
Biological Chemistry|March 16, 2013
Effects of lipotoxicity on a novel insulin-secreting human pancreatic β-cell line, 1.1B4Srividya Vasu, Neville H McClenaghan, Jane T McCluskey, et al.
Experimental Cell Research|June 2, 2015
Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicitySrividya Vasu, R Charlotte Moffett, Neville H McClenaghan, et al.
Chemmedchem|November 10, 2012
(Val(8))GLP-1-Glu-PAL: a GLP-1 agonist that improves hippocampal neurogenesis, glucose homeostasis, and β-cell function in high-fat-fed miceRachael Lennox, David W Porter, Peter R Flatt, et al.
The Journal of Endocrinology|June 11, 2024
Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?Ryan A Lafferty, Peter R Flatt, Victor A Gault, et al.
Clinical Science (London, England : 1979)|February 22, 2011
Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesityVictor A Gault, Barry D Kerr, Patrick Harriott, et al.
World Journal of Diabetes|November 30, 2016
Implanting 1.1B4 human β-cell pseudoislets improves glycaemic control in diabetic severe combined immune deficient miceAlastair D Green, Srividya Vasu, Neville H McClenaghan, et al.
Pageof 33